A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.
Clinical trial NCT00408213 · COMPLETED
Trial details
- NCT number
- NCT00408213
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.